Addition of Ondansetron to Ongoing Antipsychotic Treatment for Schizophrenia

Completed · Phase 3 · Has a placebo group

Conditions studied: Schizophrenia

In brief

This study will examine the effects of ondansetron on auditory nerve activity in people with schizophrenia who are being treated with new antipsychotics.

Key facts

Study ID

NCT00149734

Run by

University of Colorado, Denver

People needed

8

Starts

2005-01-01

Expected to finish

2010-05-01

Last updated by the study team

2021-08-13

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets DSM-IV criteria for schizophrenia
• Stable, chronic schizophrenia
• Currently taking atypical medications
• Use of effective form of contraception throughout study

You may not qualify if…

• History of any alcohol or drug abuse within 3 months of study start date
• Any other major neurological disorders
• History of or current head trauma
• Any medical conditions affecting the central nervous system
• Current epilepsy, asthma, migraine headache, previous myocardial infarction, stroke, diabetes, hypertension, narrow angle glaucoma, or neuromuscular illnesses
• Pregnant

Where it is running

• Denver VAMC — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.